FGF21 and metabolic dysfunction-associated steatotic liver disease: Moreover, the performance of FGF21 has been examined in a 3-year prospective study in China and high serum FGF21 was found to be a determinant of NAFLD, showing an area under curve of receiver operating characteristic (AUROC) of 0.81613.